Ivermectin alone or in combination with benzyl benzoate in the treatment of human immunodeficiency virus-associated scabies

British Journal of Dermatology

Volumn 142, Issue 5, 2000, Pages 969-972

  Alberici, F ^a   Pagani, Leonardo ^a   Ratti, G ^a   Viale, P ^b  

^a Ospedale di Piacenza   (Italy)

^b Clin of Infect and Trop Diseases   (Italy)

Author keywords

Acquired immune deficiency syndrome; Human immunodeficiency virus; Ivermectin; Scabies; Topical treatments

Indexed keywords

BENZYL BENZOATE; IVERMECTIN;

ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MONOTHERAPY; PRIORITY JOURNAL; RELAPSE; SCABIES; TOPICAL TREATMENT; TREATMENT FAILURE;

ADMINISTRATION, ORAL; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; ANTIPROTOZOAL AGENTS; BENZOATES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IVERMECTIN; MALE; RETROSPECTIVE STUDIES; SCABIES; SEVERITY OF ILLNESS INDEX;

EID: 0034067168     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03480.x     Document Type: Article

References (32)

1. 1 Corbett EL, Crossley I, Holton J et al. Crusted ('Norwegian') scabies in a specialist HIV unit: successful use of ivermectin and failure to prevent nosocomial transmission. Genitourin Med 1996: 72: 115-17.
2. 2 Huffam SE, Currie BJ. Ivermectin for Sarcoptes scabiei hyperinfestation. Int J Infect Dis 1998; 2: 152-4.
3. 5 Meinking TL, Taplin D, Hermida JI. et al. The treatment of scabies with ivermectin. N Engl J Med 1995; 333: 26-30.
4. 4 Nandwani R, Pozniak AL, Fuller LC, Wade J. Crusted ('Norwegian') scabies in a specialist HIV unit. Genitourin Med 1996; 72: 453-4.
5. 5 Marty P, Gari-Toussaint M, Le Fichoux Y, Gaxotte P. Efficacy of ivermectin in the treatment of an epidemic of sarcoptic scabies. Ann Trop Med Parasitol 1994; 88: 453.
6. 6 Cordoliani F, Vasseur E, Baccard M et al. Ivermectin-responsive crusted scabies in HTLV1 carrier. Dermatology 1996; 192: 351-2.
7. 7 Dunne CL, Malone CJ, Whitworth JAG. A field study of the effects of ivermectin on ectoparasites of man. Trans R Soc Trop Med Hyg 1991; 85: 550-1.
8. 8 del Giudice P, Carles M, Couppié P et al. Successful treatment of crusted (Norwegian) scabies with ivermectin in two patients with human immunodeficiency virus infection. (Letter.) Br J Dermatol 1996; 135: 494-5.
9. 9 Dourmishev A, Serafimova D, Dourmishev L. Efficacy and tolerance of oral ivermectin in scabies. J Eur Acad Dermatol Venereol 1998; 11: 247-51.
10. 10 Guggisberg D, de Viragh PA, Constantin C, Panizzon RG. Norwegian scabies in a patient with acquired immunodeficiency syndrome. Dermatology 1998; 197: 306-8.
11. 11 Taplin D, Meinking TL. Treatment of HIV-related scabies with emphasis on the efficacy of ivermectin. Semin Cutan Med Surg 1997; 16: 235-40.
12. 12 Burkhart KM, Burkhart CN, Burkhart CG. Comparing topical scabietic treatments will soon become extinct. (Letter.) Arch Dermatol 1997; 133: 1314.
13. 13 Walker GJA, Johnstone PW. Interventions for treating scabies (Cochrane Review). In: The Cochrane Library. Issue 2. Oxford: Update Software, 1999. www.update-software.com
14. 14 Funkhouser ME, Ross A, Berger TG. Management of scabies in patients with human immunodeficiency virus disease. Arch Dermatol 1993; 129: 911-13.
15. 15 Portu JJ, Santamaria JM, Zubero Z et al. Atypical scabies in HIV-positive patients. J Am Acad Dermatol 1996; 34: 915-17.
16. 16 Orkin M. Scabies in AIDS. Semin Dermatol 1993; 12: 9-14.
17. 17 Boix V, Sànchez-Payã J, Portilla J, Merino E. Nosocomial outbreak of scabies clinically resistant to lindane. (Letter.) Infect Contr Hosp Epidemiol 1997; 18: 677.
18. 18 Franz TJ, Lehman PA, Franz SF, Guin JD. Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol 1996; 132: 901-5.
19. 19 Meinking TL, Taplin D. Safety of permethrin vs. lindane for the treatment of scabies. Arch Dermatol 1996; 132: 959-62.
20. 20 Haustein UF, Hlawa B. Treatment of scabies with permethrin versus lindane and benzyl benzoate. Acta Derm Venereol (Stockh) 1989; 69: 348-51.
21. 21 Glaziou P, Cartel JL, Alzieu P et al. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol 1993; 44: 331-2.
22. 22 Brown S, Becher J, Brady W. Treatment of ectoparasitic infections: review of the English-language literature, 1982-1992. Clin Infect Dis 1995; 20 (Suppl. 1): S104-9.
23. 23 Aubin F, Humbert P. Ivermectin for crusted (Norwegian) scabies. (Letter.) N Engl J Med 1995; 332: 612.
24. 24 Pacquè M, Munoz B, Greene BM et al. Safety of and compliance with community-based ivermectin therapy. Lancet 1990; 335: 1377-80.
25. 25 Macotela-Ruiz E, Pena-Gonzales G. Tratamiento de la escabiasis con ivermectina por via oral. Gac Med Mex 1993; 129: 201-5.
26. 26 Barkwell R, Shields S. Death associated with ivermectin treatment of scabies. Lancet 1997; 349: 1144-5. (Replies in Lancet 1997; 350: 215-6 and Lancet 1997; 350: 1551.)
27. 27 Sullivan JR, Watt G, Barker B. Successful use of ivermectin in the treatment of endemic scabies in a nursing home. Australas J Dermatol 1997; 38: 137-40.
28. 28 Alexander NDE, Bockaric MJ, Kastens WA et al. Absence of ivermectin-associated excess deaths. (Letter.) Trans R Soc Trop Med Hyg 1998; 92: 342.
29. 29 del Giudice P, Marty P. Ivermectin in elderly patients. (Letter.) Arch Dermatol 1999; 135: 351-2.
30. 30 del Giudice P, Marty P. Ivermectin: a new therapeutic weapon in dermatology? Arch Dermatol 1999; 135: 705-6.
31. 31 Chouela EN, Abeldaño AM, Pellerano G et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermatol 1999; 135: 651-5.
32. 32 Dannaoui E, Kiazand A, Piens M, Picot S. Use of ivermectin for the management of scabies in a nursing home. Eur J Dermatol 1999; 9: 443-5.